Ultrafast dynamic contrast-enhanced breast MRI may generate prognostic imaging markers of breast cancer

[1]  Kaori Togashi,et al.  New parameters of ultrafast dynamic contrast‐enhanced breast MRI using compressed sensing , 2020, Journal of magnetic resonance imaging : JMRI.

[2]  M. Iima,et al.  Diagnostic performance of maximum slope: A kinetic parameter obtained from ultrafast dynamic contrast-enhanced magnetic resonance imaging of the breast using k-space weighted image contrast (KWIC). , 2019, European journal of radiology.

[3]  Brittany Z Dashevsky,et al.  Differentiation between subcentimeter carcinomas and benign lesions using kinetic parameters derived from ultrafast dynamic contrast-enhanced breast MRI , 2019, European Radiology.

[4]  Danny F. Martinez,et al.  Characterization of Sub‐1 cm Breast Lesions Using Radiomics Analysis , 2019, Journal of magnetic resonance imaging : JMRI.

[5]  Luca Maria Sconfienza,et al.  Sarcopenia: ultrasound today, smartphones tomorrow? , 2018, European Radiology.

[6]  E. Weiland,et al.  Diagnostic performance of initial enhancement analysis using ultra-fast dynamic contrast-enhanced MRI for breast lesions , 2018, European Radiology.

[7]  Kaori Togashi,et al.  Ultrafast dynamic contrast‐enhanced mri of the breast using compressed sensing: breast cancer diagnosis based on separate visualization of breast arteries and veins , 2018, Journal of magnetic resonance imaging : JMRI.

[8]  Jun Shen,et al.  Discrimination between benign and malignant breast lesions using volumetric quantitative dynamic contrast-enhanced MR imaging , 2018, European Radiology.

[9]  Publisher's Note , 2018, Anaesthesia.

[10]  Nico Karssemeijer,et al.  Time to enhancement derived from ultrafast breast MRI as a novel parameter to discriminate benign from malignant breast lesions. , 2017, European journal of radiology.

[11]  Hiroyuki Abe,et al.  Ultrafast Bilateral DCE-MRI of the Breast with Conventional Fourier Sampling: Preliminary Evaluation of Semi-quantitative Analysis. , 2016, Academic radiology.

[12]  Hiroyuki Abe,et al.  Kinetic Analysis of Benign and Malignant Breast Lesions With Ultrafast Dynamic Contrast-Enhanced MRI: Comparison With Standard Kinetic Assessment. , 2016, AJR. American journal of roentgenology.

[13]  Ron Kikinis,et al.  Bolus arrival time and its effect on tissue characterization with dynamic contrast-enhanced magnetic resonance imaging , 2016, Journal of medical imaging.

[14]  Nico Karssemeijer,et al.  A Novel Approach to Contrast-Enhanced Breast Magnetic Resonance Imaging for Screening: High-Resolution Ultrafast Dynamic Imaging , 2014, Investigative radiology.

[15]  Ralf-Dieter Hilgers,et al.  Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Frédéric Courivaud,et al.  T2*‐correction in dynamic contrast‐enhanced MRI from double‐echo acquisitions , 2014, Journal of magnetic resonance imaging : JMRI.

[17]  Nico Karssemeijer,et al.  Automated Characterization of Breast Lesions Imaged With an Ultrafast DCE-MR Protocol , 2014, IEEE Transactions on Medical Imaging.

[18]  D Balvay,et al.  Perfusion and vascular permeability: basic concepts and measurement in DCE-CT and DCE-MRI. , 2013, Diagnostic and interventional imaging.

[19]  G. Santamaría,et al.  Dynamic Contrast‐Enhanced MRI Reveals the Extent and the Microvascular Pattern of Breast Ductal Carcinoma In Situ , 2013, The breast journal.

[20]  R. Jain.  Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Wei Huang,et al.  Signal-to-noise ratio, contrast-to-noise ratio and pharmacokinetic modeling considerations in dynamic contrast-enhanced magnetic resonance imaging. , 2012, Magnetic resonance imaging.

[22]  Henkjan Huisman,et al.  Comparison of enhancement characteristics between invasive lobular carcinoma and invasive ductal carcinoma , 2011, Journal of magnetic resonance imaging : JMRI.

[23]  Werner A. Kaiser,et al.  Computer-aided interpretation of dynamic magnetic resonance imaging reflects histopathology of invasive breast cancer , 2010, European Radiology.

[24]  S S Cross,et al.  Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease , 2009, British Journal of Cancer.

[25]  C. Boetes,et al.  Breast MRI: guidelines from the European Society of Breast Imaging , 2008, European Radiology.

[26]  W. B. Veldhuis,et al.  Contrast-enhanced 3.0-T breast MRI for characterization of breast lesions: increased specificity by using vascular maps , 2008, European Radiology.

[27]  R. Schmidt,et al.  Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade. , 2007, Radiology.

[28]  C. Kuhl.  The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. , 2007, Radiology.

[29]  Ritse M. Mann,et al.  MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature , 2007, Breast Cancer Research and Treatment.

[30]  Huanzhou Yu,et al.  Relaxation times of breast tissue at 1.5T and 3T measured using IDEAL , 2006, Journal of magnetic resonance imaging : JMRI.

[31]  P. Parizel,et al.  Comparison of MRI features of different grades of DCIS and invasive carcinoma of the breast. , 2006, JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie.

[32]  Hans H Schild,et al.  Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution. , 2005, Radiology.

[33]  Alessandro Carriero,et al.  Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity. , 2005, Radiology.

[34]  A. Santinelli,et al.  Microvessel quantitation in intraductal and early invasive breast carcinomas. , 2000, Analytical and quantitative cytology and histology.

[35]  W E Reddick,et al.  Evolution from empirical dynamic contrast-enhanced magnetic resonance imaging to pharmacokinetic MRI. , 2000, Advanced drug delivery reviews.

[36]  R. Gilles,et al.  Ductal carcinoma in situ: MR imaging-histopathologic correlation. , 1995, Radiology.

[37]  Anthony J. Guidi,et al.  Microvessel density and distribution in ductal carcinoma in situ of the breast. , 1994, Journal of the National Cancer Institute.

[38]  D. Cicchetti.  Guidelines, Criteria, and Rules of Thumb for Evaluating Normed and Standardized Assessment Instruments in Psychology. , 1994 .

[39]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.